Is the cardiovascular system a therapeutic target for cannabidiol?

Por Stanley, Christopher P, Hind, William H, O'Sullivan, Saoirse E
Publicado em 2013

Cannabidiol protects an in vitro model of the blood–brain barrier from oxygen‐glucose deprivation via PPARγ and 5‐HT(1A) receptors

Por Hind, William H, England, Timothy J, O'Sullivan, Saoirse E
Publicado no Br J Pharmacol (2016)

Cannabidiol causes endothelium-dependent vasorelaxation of human mesenteric arteries via CB(1) activation

Por Stanley, Christopher P., Hind, William H., Tufarelli, Cristina, O'Sullivan, Saoirse E.
Publicado no Cardiovasc Res (2015)

The endocannabinoid anandamide causes endothelium-dependent vasorelaxation in human mesenteric arteries

Por Stanley, Christopher P., Hind, William H., Tufarelli, Christina, O’Sullivan, Saoirse E.
Publicado no Pharmacol Res (2016)

Cannabinoids in experimental stroke: a systematic review and meta-analysis

Por England, Timothy J, Hind, William H, Rasid, Nadiah A, O'Sullivan, Saoirse E
Publicado no J Cereb Blood Flow Metab (2015)

Endocannabinoids modulate human blood–brain barrier permeability in vitro

Por Hind, William H, Tufarelli, Cristina, Neophytou, Maria, Anderson, Susan I, England, Timothy J, O'Sullivan, Saoirse E
Publicado no Br J Pharmacol (2015)